Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment.
Shoenfeld
Y
Y
Department of Medicine B and Research Center of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel. shoenfel@post.tau.ac.il
Levy
Y
Y
Fishman
P
P
D000328:Adult; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008197:Lymph Node Excision; D008297:Male; D008545:Melanoma / Q000473:pathology*; D009506:Nevus / Q000473:pathology; D017211:Treatment Failure
D016756:Immunoglobulins, Intravenous